HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ECHA Proposes Oxybenzone, Glycolic Acid For Next REACH Review

This article was originally published in The Rose Sheet

Executive Summary

Sunscreen agent oxybenzone and cosmetic ingredient glycolic acid are among ECHA’s latest nominees for evaluation under REACH.

You may also be interested in...

ECHA Publishes Toluene Evaluation; New Exposure Limits Recommended

A substance evaluation on toluene conducted under the European Union’s REACH program affirms previous risk assessments but recommends another look at exposure limits in the workplace.

ECHA Expands Proposed REACH Review List By 63 Ingredients

Sunscreen ingredient benzophenone and nail ingredient methacrylic acid included on CoRAP draft list of new substances proposed for evaluation under REACH chemicals legislation. Substances are slated to be divided among EU member states for evaluation over next three years.

ECHA Proposes Formaldehyde, Ti02 Among Substances For REACH Evaluation

The European Chemicals Agency has released a first draft list of substances that could be subject to review under the Registration, Evaluation, Authorization and Restriction of Chemicals substance evaluation process.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts